Abstract
It is estimated that ∼1% of the world's population has intellectual disability, with males affected more often than females. OGT is an X-linked gene encoding for the enzyme O-GlcNAc transferase (OGT), which carries out the reversible addition of N-acetylglucosamine (GlcNAc) to Ser/Thr residues of its intracellular substrates. Three missense mutations in the tetratricopeptide (TPR) repeats of OGT have recently been reported to cause X-linked intellectual disability (XLID). Here, we report the discovery of two additional novel missense mutations (c.775 G>A, p.A259T, and c.1016 A>G, p.E339G) in the TPR domain of OGT that segregate with XLID in affected families. Characterization of all five of these XLID missense variants of OGT demonstrates modest declines in thermodynamic stability and/or activities of the variants. We engineered each of the mutations into a male human embryonic stem cell line using CRISPR/Cas9. Investigation of the global O-GlcNAc profile as well as OGT and O-GlcNAc hydrolase levels by Western blotting showed no gross changes in steady-state levels in the engineered lines. However, analyses of the differential transcriptomes of the OGT variant-expressing stem cells revealed shared deregulation of genes involved in cell fate determination and liver X receptor/retinoid X receptor signaling, which has been implicated in neuronal development. Thus, here we reveal two additional mutations encoding residues in the TPR regions of OGT that appear causal for XLID and provide evidence that the relatively stable and active TPR variants may share a common, unelucidated mechanism of altering gene expression profiles in human embryonic stem cells.
Highlights
It is estimated that ϳ1% of the world’s population has intellectual disability, with males affected more often than females
Using exome sequencing to determine the etiology of the disease, we discover two separate novel missense mutations in the tetratricopeptide repeats (TPRs) domain of O-GlcNAc transferase (OGT) that segregate with X-linked Intellectual disability (ID) (XLID) in these patients
It was unsurprising that we found no significant changes (CTD 110.6, p Ͼ 0.4; RL2, p Ͼ 0.7; MannWhitney U test, data not shown) in the levels of O-GlcNAc in the X-linked intellectual disability (XLID) OGT-TPR mutant-expressing lines compared with WT (Fig. 5, a and b)
Summary
Three missense mutations in the tetratricopeptide (TPR) repeats of OGT have recently been reported to cause X-linked intellectual disability (XLID). Two additional mutations encoding residues in the TPR regions of OGT that appear causal for XLID and provide evidence that the relatively stable and active TPR variants may share a common, unelucidated mechanism of altering gene expression profiles in human embryonic stem cells. Using exome sequencing to determine the etiology of the disease, we discover two separate novel missense mutations in the TPR domain of OGT that segregate with X-linked ID (XLID) in these patients. To use as an ex vivo human isogenic model to study the effects of the XLID mutations on early development and disease pathogenesis, we engineered a human male embryonic stem cell line using CRISPR/Cas to express these OGT variants. Analysis of the transcriptome of these cells, reveals shared dysregulation of genes and pathways involved in early development, providing a starting point for dissecting the impact of OGT variants on common phenotypes in the XLID-affected individuals
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.